TP53 and breast carcinoma: Although several key genes are identified to be mutated or deregulated in breast cancer such as HER2, P53, cyclin E, and BRCA1/2 which are involved in tumorigenesis, progression and metastasis [22,23], the novel molecular markers are urgently needed for identifying tumor spread and aiding risk assessment.